EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE

PURPOSE: To evaluate intravitreal aflibercept in macular telangiectasia Type 1 (MacTel 1) patients and measure their ocular angiogenic profile. METHODS: Eight subjects with MacTel 1 refractory to bevacizumab, ranibizumab, or laser therapy and switched to aflibercept were included. Best-corrected vis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Retina
Autors principals: Kowalczuk, Laura, Matet, Alexandre, Dirani, Ali, Daruich, Alejandra, Ambresin, Aude, Mantel, Irmela, Spaide, Richard F., Turck, Natacha, Behar-Cohen, Francine
Format: Artigo
Idioma:Inglês
Publicat: Retina 2017
Matèries:
Original Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732636/
https://ncbi.nlm.nih.gov/pubmed/28002269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000001424
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars